Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
International Journal of Nanomedicine
|
September 19, 2017
Composite iron oxide-Prussian blue nanoparticles for magnetically guided T<sub>1</sub>-weighted magnetic resonance imaging and photothermal therapy of tumors
Shraddha S Kale, Rachel A Burga, Elizabeth E Sweeney, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
Juliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.
Journal of Leukocyte Biology
|
July 26, 2013
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils
Lauren A Licata, Cang T Nguyen, Rachel A Burga, et al.
Nano Research
|
June 3, 2021
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function
Elizabeth E Sweeney, Preethi B Balakrishnan, Allison B Powell, et al.
Frontiers in Oncology
|
April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
Shabnum Patel, Rachel A Burga, Allison B Powell, et al.
Journal of Translational Medicine
|
February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
Steven C Katz, Rachel A Burga, Seema Naheed, et al.
Cancer Immunology, Immunotherapy : CII
|
April 9, 2015
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
Rachel A Burga, Mitchell Thorn, Gary R Point, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2015
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
Steven C Katz, Rachel A Burga, Elise McCormack, et al.
Journal of Translational Medicine
|
September 25, 2019
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
Allison B Powell, Sridevi Yadavilli, Devin Saunders, et al.
The Journal of Experimental Medicine
|
September 29, 2020
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
Catalina Lee-Chang, Jason Miska, David Hou, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
International Journal of Nanomedicine
|
September 19, 2017
Composite iron oxide-Prussian blue nanoparticles for magnetically guided T<sub>1</sub>-weighted magnetic resonance imaging and photothermal therapy of tumors
Shraddha S Kale, Rachel A Burga, Elizabeth E Sweeney, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
Juliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.
Journal of Leukocyte Biology
|
July 26, 2013
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils
Lauren A Licata, Cang T Nguyen, Rachel A Burga, et al.
Nano Research
|
June 3, 2021
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function
Elizabeth E Sweeney, Preethi B Balakrishnan, Allison B Powell, et al.
Frontiers in Oncology
|
April 27, 2019
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
Shabnum Patel, Rachel A Burga, Allison B Powell, et al.
Journal of Translational Medicine
|
February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
Steven C Katz, Rachel A Burga, Seema Naheed, et al.
Cancer Immunology, Immunotherapy : CII
|
April 9, 2015
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
Rachel A Burga, Mitchell Thorn, Gary R Point, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2015
Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
Steven C Katz, Rachel A Burga, Elise McCormack, et al.
Journal of Translational Medicine
|
September 25, 2019
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
Allison B Powell, Sridevi Yadavilli, Devin Saunders, et al.
The Journal of Experimental Medicine
|
September 29, 2020
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
Catalina Lee-Chang, Jason Miska, David Hou, et al.
Page
of 3